AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.44B
PWJZX
Price
$34.32
Change
+$0.02 (+0.06%)
Updated
Jun 5 closing price
Net Assets
5.5B
Interact to see
Advertisement

AEPCX vs PWJZX

Header iconAEPCX vs PWJZX Comparison
Open Charts AEPCX vs PWJZXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.44B
PGIM Jennison International Opps Z
Price$34.32
Change+$0.02 (+0.06%)
VolumeN/A
Net Assets5.5B
AEPCX vs PWJZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. PWJZX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and PWJZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. PWJZX (5.5B). AEPCX pays higher dividends than PWJZX: AEPCX (0.32) vs PWJZX (0.07). AEPCX was incepted earlier than PWJZX: AEPCX (24 years) vs PWJZX (13 years). AEPCX (1.59) is less costly to investors than PWJZX (0.95). PWJZX is a more actively managed with annual turnover of: 44.00 vs. AEPCX (30.00). PWJZX has a lower initial minimum investment than AEPCX: PWJZX (0) vs AEPCX (250). PWJZX annual gain was more profitable for investors over the last year : 8.18 vs. AEPCX (2.04). PWJZX return over 5 years is better than : 43.27 vs. AEPCX (14.22).
AEPCXPWJZXAEPCX / PWJZX
Total Expense Ratio1.590.90177%
Annual Report Gross Expense Ratio1.590.95167%
Fund Existence24 years13 years-
Gain YTD12.50213.16495%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B5.5B2,417%
Annual Yield % from dividends0.320.07484%
Returns for 1 year2.048.1825%
Returns for 3 years14.8236.9340%
Returns for 5 years14.2243.2733%
Returns for 10 years20.67146.4914%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.